Table of Contents Chapter 1 Overview of Foot Ulcer Therapeutic 1.1 Definition of Foot Ulcer Therapeutic in This Report 1.2 Commercial Types of Foot Ulcer Therapeutic 1.2.1 Advance Wound Dressings 1.2.2 Skin Substitutes 1.2.3 Negative Pressure Wound Therapy Devices 1.3 Downstream Application of Foot Ulcer Therapeutic 1.3.1 Hospitals 1.3.2 Specialty Clinics 1.3.3 Long-Term Care Centers 1.3.4 Ambulatory Surgical Centers 1.4 Development History of Foot Ulcer Therapeutic 1.5 Market Status and Trend of Foot Ulcer Therapeutic 2013-2023 1.5.1 Global Foot Ulcer Therapeutic Market Status and Trend 2013-2023 1.5.2 Regional Foot Ulcer Therapeutic Market Status and Trend 2013-2023 Chapter 2 Global Market Status and Forecast by Regions 2.1 Market Development of Foot Ulcer Therapeutic 2013-2017 2.2 Sales Market of Foot Ulcer Therapeutic by Regions 2.2.1 Sales Volume of Foot Ulcer Therapeutic by Regions 2.2.2 Sales Value of Foot Ulcer Therapeutic by Regions 2.3 Production Market of Foot Ulcer Therapeutic by Regions 2.4 Global Market Forecast of Foot Ulcer Therapeutic 2018-2023 2.4.1 Global Market Forecast of Foot Ulcer Therapeutic 2018-2023 2.4.2 Market Forecast of Foot Ulcer Therapeutic by Regions 2018-2023 Chapter 3 Global Market Status and Forecast by Types 3.1 Sales Volume of Foot Ulcer Therapeutic by Types 3.2 Sales Value of Foot Ulcer Therapeutic by Types 3.3 Market Forecast of Foot Ulcer Therapeutic by Types Chapter 4 Global Market Status and Forecast by Downstream Industry 4.1 Global Sales Volume of Foot Ulcer Therapeutic by Downstream Industry 4.2 Global Market Forecast of Foot Ulcer Therapeutic by Downstream Industry Chapter 5 North America Market Status by Countries, Type, Manufacturers and Downstream Industry 5.1 North America Foot Ulcer Therapeutic Market Status by Countries 5.1.1 North America Foot Ulcer Therapeutic Sales by Countries (2013-2017) 5.1.2 North America Foot Ulcer Therapeutic Revenue by Countries (2013-2017) 5.1.3 United States Foot Ulcer Therapeutic Market Status (2013-2017) 5.1.4 Canada Foot Ulcer Therapeutic Market Status (2013-2017) 5.1.5 Mexico Foot Ulcer Therapeutic Market Status (2013-2017) 5.2 North America Foot Ulcer Therapeutic Market Status by Manufacturers 5.3 North America Foot Ulcer Therapeutic Market Status by Type (2013-2017) 5.3.1 North America Foot Ulcer Therapeutic Sales by Type (2013-2017) 5.3.2 North America Foot Ulcer Therapeutic Revenue by Type (2013-2017) 5.4 North America Foot Ulcer Therapeutic Market Status by Downstream Industry (2013-2017) Chapter 6 Europe Market Status by Countries, Type, Manufacturers and Downstream Industry 6.1 Europe Foot Ulcer Therapeutic Market Status by Countries 6.1.1 Europe Foot Ulcer Therapeutic Sales by Countries (2013-2017) 6.1.2 Europe Foot Ulcer Therapeutic Revenue by Countries (2013-2017) 6.1.3 Germany Foot Ulcer Therapeutic Market Status (2013-2017) 6.1.4 UK Foot Ulcer Therapeutic Market Status (2013-2017) 6.1.5 France Foot Ulcer Therapeutic Market Status (2013-2017) 6.1.6 Italy Foot Ulcer Therapeutic Market Status (2013-2017) 6.1.7 Russia Foot Ulcer Therapeutic Market Status (2013-2017) 6.1.8 Spain Foot Ulcer Therapeutic Market Status (2013-2017) 6.1.9 Benelux Foot Ulcer Therapeutic Market Status (2013-2017) 6.2 Europe Foot Ulcer Therapeutic Market Status by Manufacturers 6.3 Europe Foot Ulcer Therapeutic Market Status by Type (2013-2017) 6.3.1 Europe Foot Ulcer Therapeutic Sales by Type (2013-2017) 6.3.2 Europe Foot Ulcer Therapeutic Revenue by Type (2013-2017) 6.4 Europe Foot Ulcer Therapeutic Market Status by Downstream Industry (2013-2017) Chapter 7 Asia Pacific Market Status by Countries, Type, Manufacturers and Downstream Industry 7.1 Asia Pacific Foot Ulcer Therapeutic Market Status by Countries 7.1.1 Asia Pacific Foot Ulcer Therapeutic Sales by Countries (2013-2017) 7.1.2 Asia Pacific Foot Ulcer Therapeutic Revenue by Countries (2013-2017) 7.1.3 China Foot Ulcer Therapeutic Market Status (2013-2017) 7.1.4 Japan Foot Ulcer Therapeutic Market Status (2013-2017) 7.1.5 India Foot Ulcer Therapeutic Market Status (2013-2017) 7.1.6 Southeast Asia Foot Ulcer Therapeutic Market Status (2013-2017) 7.1.7 Australia Foot Ulcer Therapeutic Market Status (2013-2017) 7.2 Asia Pacific Foot Ulcer Therapeutic Market Status by Manufacturers 7.3 Asia Pacific Foot Ulcer Therapeutic Market Status by Type (2013-2017) 7.3.1 Asia Pacific Foot Ulcer Therapeutic Sales by Type (2013-2017) 7.3.2 Asia Pacific Foot Ulcer Therapeutic Revenue by Type (2013-2017) 7.4 Asia Pacific Foot Ulcer Therapeutic Market Status by Downstream Industry (2013-2017) Chapter 8 Latin America Market Status by Countries, Type, Manufacturers and Downstream Industry 8.1 Latin America Foot Ulcer Therapeutic Market Status by Countries 8.1.1 Latin America Foot Ulcer Therapeutic Sales by Countries (2013-2017) 8.1.2 Latin America Foot Ulcer Therapeutic Revenue by Countries (2013-2017) 8.1.3 Brazil Foot Ulcer Therapeutic Market Status (2013-2017) 8.1.4 Argentina Foot Ulcer Therapeutic Market Status (2013-2017) 8.1.5 Colombia Foot Ulcer Therapeutic Market Status (2013-2017) 8.2 Latin America Foot Ulcer Therapeutic Market Status by Manufacturers 8.3 Latin America Foot Ulcer Therapeutic Market Status by Type (2013-2017) 8.3.1 Latin America Foot Ulcer Therapeutic Sales by Type (2013-2017) 8.3.2 Latin America Foot Ulcer Therapeutic Revenue by Type (2013-2017) 8.4 Latin America Foot Ulcer Therapeutic Market Status by Downstream Industry (2013-2017) Chapter 9 Middle East and Africa Market Status by Countries, Type, Manufacturers and Downstream Industry 9.1 Middle East and Africa Foot Ulcer Therapeutic Market Status by Countries 9.1.1 Middle East and Africa Foot Ulcer Therapeutic Sales by Countries (2013-2017) 9.1.2 Middle East and Africa Foot Ulcer Therapeutic Revenue by Countries (2013-2017) 9.1.3 Middle East Foot Ulcer Therapeutic Market Status (2013-2017) 9.1.4 Africa Foot Ulcer Therapeutic Market Status (2013-2017) 9.2 Middle East and Africa Foot Ulcer Therapeutic Market Status by Manufacturers 9.3 Middle East and Africa Foot Ulcer Therapeutic Market Status by Type (2013-2017) 9.3.1 Middle East and Africa Foot Ulcer Therapeutic Sales by Type (2013-2017) 9.3.2 Middle East and Africa Foot Ulcer Therapeutic Revenue by Type (2013-2017) 9.4 Middle East and Africa Foot Ulcer Therapeutic Market Status by Downstream Industry (2013-2017) Chapter 10 Market Driving Factor Analysis of Foot Ulcer Therapeutic 10.1 Global Economy Situation and Trend Overview 10.2 Foot Ulcer Therapeutic Downstream Industry Situation and Trend Overview Chapter 11 Foot Ulcer Therapeutic Market Competition Status by Major Manufacturers 11.1 Production Volume of Foot Ulcer Therapeutic by Major Manufacturers 11.2 Production Value of Foot Ulcer Therapeutic by Major Manufacturers 11.3 Basic Information of Foot Ulcer Therapeutic by Major Manufacturers 11.3.1 Headquarters Location and Established Time of Foot Ulcer Therapeutic Major Manufacturer 11.3.2 Employees and Revenue Level of Foot Ulcer Therapeutic Major Manufacturer 11.4 Market Competition News and Trend 11.4.1 Merger, Consolidation or Acquisition News 11.4.2 Investment or Disinvestment News 11.4.3 New Product Development and Launch Chapter 12 Foot Ulcer Therapeutic Major Manufacturers Introduction and Market Data 12.1 B. Braun Melsungen AG 12.1.1 Company profile 12.1.2 Representative Foot Ulcer Therapeutic Product 12.1.3 Foot Ulcer Therapeutic Sales, Revenue, Price and Gross Margin of B. Braun Melsungen AG 12.2 Smith & Nephew, Inc. 12.2.1 Company profile 12.2.2 Representative Foot Ulcer Therapeutic Product 12.2.3 Foot Ulcer Therapeutic Sales, Revenue, Price and Gross Margin of Smith & Nephew, Inc. 12.3 Organogenesis, Inc. 12.3.1 Company profile 12.3.2 Representative Foot Ulcer Therapeutic Product 12.3.3 Foot Ulcer Therapeutic Sales, Revenue, Price and Gross Margin of Organogenesis, Inc. 12.4 Derma Sciences Inc. 12.4.1 Company profile 12.4.2 Representative Foot Ulcer Therapeutic Product 12.4.3 Foot Ulcer Therapeutic Sales, Revenue, Price and Gross Margin of Derma Sciences Inc. 12.5 Sigvaris Inc. 12.5.1 Company profile 12.5.2 Representative Foot Ulcer Therapeutic Product 12.5.3 Foot Ulcer Therapeutic Sales, Revenue, Price and Gross Margin of Sigvaris Inc. 12.6 3M 12.6.1 Company profile 12.6.2 Representative Foot Ulcer Therapeutic Product 12.6.3 Foot Ulcer Therapeutic Sales, Revenue, Price and Gross Margin of 3M 12.7 Acelity L.P. Inc. 12.7.1 Company profile 12.7.2 Representative Foot Ulcer Therapeutic Product 12.7.3 Foot Ulcer Therapeutic Sales, Revenue, Price and Gross Margin of Acelity L.P. Inc. 12.8 Innocoll Holdings plc. 12.8.1 Company profile 12.8.2 Representative Foot Ulcer Therapeutic Product 12.8.3 Foot Ulcer Therapeutic Sales, Revenue, Price and Gross Margin of Innocoll Holdings plc. 12.9 SIGVARIS, Inc. 12.9.1 Company profile 12.9.2 Representative Foot Ulcer Therapeutic Product 12.9.3 Foot Ulcer Therapeutic Sales, Revenue, Price and Gross Margin of SIGVARIS, Inc. Chapter 13 Upstream and Downstream Market Analysis of Foot Ulcer Therapeutic 13.1 Industry Chain of Foot Ulcer Therapeutic 13.2 Upstream Market and Representative Companies Analysis 13.3 Downstream Market and Representative Companies Analysis Chapter 14 Cost and Gross Margin Analysis of Foot Ulcer Therapeutic 14.1 Cost Structure Analysis of Foot Ulcer Therapeutic 14.2 Raw Materials Cost Analysis of Foot Ulcer Therapeutic 14.3 Labor Cost Analysis of Foot Ulcer Therapeutic 14.4 Manufacturing Expenses Analysis of Foot Ulcer Therapeutic Chapter 15 Report Conclusion Chapter 16 Research Methodology and Reference 16.1 Methodology/Research Approach 16.1.1 Research Programs/Design 16.1.2 Market Size Estimation 16.1.3 Market Breakdown and Data Triangulation 16.2 Data Source 16.2.1 Secondary Sources 16.2.2 Primary Sources 16.3 Reference

List of Tables Table Advantage and Disadvantage of Advance Wound Dressings Table Advantage and Disadvantage of Skin Substitutes Table Advantage and Disadvantage of Negative Pressure Wound Therapy Devices Table Sales Volume of Foot Ulcer Therapeutic by Regions 2013-2017 Table Sales Value of Foot Ulcer Therapeutic by Regions 2013-2017 Table Production Volume of Foot Ulcer Therapeutic by Regions 2013-2017 Table Global Sales Volume of Foot Ulcer Therapeutic by Regions 2018-2023 Table Global Sales Value of Foot Ulcer Therapeutic by Regions 2018-2023 Table Global Production Volume of Foot Ulcer Therapeutic by Regions 2018-2023 Table Sales Volume of Foot Ulcer Therapeutic by Types 2013-2017 Table Sales Value of Foot Ulcer Therapeutic by Types 2013-2017 Table Sales Volume Forecast of Foot Ulcer Therapeutic by Types 2018-2023 Table Sales Value Forecast of Foot Ulcer Therapeutic by Types 2018-2023 Table Sales Volume of Foot Ulcer Therapeutic by Downstream Industry 2013-2017 Table Sales Volume Forecast of Foot Ulcer Therapeutic by Downstream Industry 2018-2023 Table North America Foot Ulcer Therapeutic Sales by Countries (2013-2017) Table North America Foot Ulcer Therapeutic Sales Share by Countries (2013-2017) Table North America Foot Ulcer Therapeutic Revenue by Countries (2013-2017) Table North America Foot Ulcer Therapeutic Revenue Market Share by Countries (2013-2017) Table North America Foot Ulcer Therapeutic Sales by Type (2013-2017) Table North America Foot Ulcer Therapeutic Sales Share by Type (2013-2017) Table North America Foot Ulcer Therapeutic Revenue by Type (2013-2017) Table North America Foot Ulcer Therapeutic Revenue Share by Type (2013-2017) Table North America Foot Ulcer Therapeutic Sales by Downstream Industry (2013-2017) Table North America Foot Ulcer Therapeutic Sales Share by Downstream Industry (2013-2017) Table Europe Foot Ulcer Therapeutic Sales by Countries (2013-2017) Table Europe Foot Ulcer Therapeutic Sales Share by Countries (2013-2017) Table Europe Foot Ulcer Therapeutic Revenue by Countries (2013-2017) Table Europe Foot Ulcer Therapeutic Revenue Market Share by Countries (2013-2017) Table Europe Foot Ulcer Therapeutic Sales by Type (2013-2017) Table Europe Foot Ulcer Therapeutic Sales Share by Type (2013-2017) Table Europe Foot Ulcer Therapeutic Revenue by Type (2013-2017) Table Europe Foot Ulcer Therapeutic Revenue Share by Type (2013-2017) Table Europe Foot Ulcer Therapeutic Sales by Downstream Industry (2013-2017) Table Europe Foot Ulcer Therapeutic Sales Share by Downstream Industry (2013-2017) Table Asia Pacific Foot Ulcer Therapeutic Sales by Countries (2013-2017) Table Asia Pacific Foot Ulcer Therapeutic Sales Share by Countries (2013-2017) Table Asia Pacific Foot Ulcer Therapeutic Revenue by Countries (2013-2017) Table Asia Pacific Foot Ulcer Therapeutic Revenue Market Share by Countries (2013-2017) Table Asia Pacific Foot Ulcer Therapeutic Sales by Type (2013-2017) Table Asia Pacific Foot Ulcer Therapeutic Sales Share by Type (2013-2017) Table Asia Pacific Foot Ulcer Therapeutic Revenue by Type (2013-2017) Table Asia Pacific Foot Ulcer Therapeutic Revenue Share by Type (2013-2017) Table Asia Pacific Foot Ulcer Therapeutic Sales by Downstream Industry (2013-2017) Table Asia Pacific Foot Ulcer Therapeutic Sales Share by Downstream Industry (2013-2017) Table Latin America Foot Ulcer Therapeutic Sales by Countries (2013-2017) Table Latin America Foot Ulcer Therapeutic Sales Share by Countries (2013-2017) Table Latin America Foot Ulcer Therapeutic Revenue by Countries (2013-2017) Table Latin America Foot Ulcer Therapeutic Revenue Market Share by Countries (2013-2017) Table Latin America Foot Ulcer Therapeutic Sales by Type (2013-2017) Table Latin America Foot Ulcer Therapeutic Sales Share by Type (2013-2017) Table Latin America Foot Ulcer Therapeutic Revenue by Type (2013-2017) Table Latin America Foot Ulcer Therapeutic Revenue Share by Type (2013-2017) Table Latin America Foot Ulcer Therapeutic Sales by Downstream Industry (2013-2017) Table Latin America Foot Ulcer Therapeutic Sales Share by Downstream Industry (2013-2017) Table Middle East and Africa Foot Ulcer Therapeutic Sales by Regions (2013-2017) Table Middle East and Africa Foot Ulcer Therapeutic Sales Share by Regions (2013-2017) Table Middle East and Africa Foot Ulcer Therapeutic Revenue by Regions (2013-2017) Table Middle East and Africa Foot Ulcer Therapeutic Revenue Market Share by Regions (2013-2017) Table Middle East and Africa Foot Ulcer Therapeutic Sales by Type (2013-2017) Table Middle East and Africa Foot Ulcer Therapeutic Sales Share by Type (2013-2017) Table Middle East and Africa Foot Ulcer Therapeutic Revenue by Type (2013-2017) Table Middle East and Africa Foot Ulcer Therapeutic Revenue Share by Type (2013-2017) Table Middle East and Africa Foot Ulcer Therapeutic Sales by Downstream Industry (2013-2017) Table Middle East and Africa Foot Ulcer Therapeutic Sales Share by Downstream Industry (2013-2017) Table Production Volume of Foot Ulcer Therapeutic by Major Manufacturers 2013-2017 Table Production Value of Foot Ulcer Therapeutic by Major Manufacturers 2013-2017 Table Headquarters Location and Established Time of Foot Ulcer Therapeutic Major Manufacturer Table Employees and Revenue Level of Foot Ulcer Therapeutic Major Manufacturer Table Representative Foot Ulcer Therapeutic Product One of B. Braun Melsungen AG Table Representative Foot Ulcer Therapeutic Product Two of B. Braun Melsungen AG Table Foot Ulcer Therapeutic Sales, Revenue, Price and Gross Margin of B. Braun Melsungen AG 2013-2017 Table Representative Foot Ulcer Therapeutic Product One of Smith & Nephew, Inc. Table Representative Foot Ulcer Therapeutic Product Two of Smith & Nephew, Inc. Table Foot Ulcer Therapeutic Sales, Revenue, Price and Gross Margin of Smith & Nephew, Inc. 2013-2017 Table Representative Foot Ulcer Therapeutic Product One of Organogenesis, Inc. Table Representative Foot Ulcer Therapeutic Product Two of Organogenesis, Inc. Table Foot Ulcer Therapeutic Sales, Revenue, Price and Gross Margin of Organogenesis, Inc. 2013-2017 Table Representative Foot Ulcer Therapeutic Product One of Derma Sciences Inc. Table Representative Foot Ulcer Therapeutic Product Two of Derma Sciences Inc. Table Foot Ulcer Therapeutic Sales, Revenue, Price and Gross Margin of Derma Sciences Inc. 2013-2017 Table Representative Foot Ulcer Therapeutic Product One of Sigvaris Inc. Table Representative Foot Ulcer Therapeutic Product Two of Sigvaris Inc. Table Foot Ulcer Therapeutic Sales, Revenue, Price and Gross Margin of Sigvaris Inc. 2013-2017 Table Representative Foot Ulcer Therapeutic Product One of 3M Table Representative Foot Ulcer Therapeutic Product Two of 3M Table Foot Ulcer Therapeutic Sales, Revenue, Price and Gross Margin of 3M 2013-2017 Table Representative Foot Ulcer Therapeutic Product One of Acelity L.P. Inc. Table Representative Foot Ulcer Therapeutic Product Two of Acelity L.P. Inc. Table Foot Ulcer Therapeutic Sales, Revenue, Price and Gross Margin of Acelity L.P. Inc. 2013-2017 Table Representative Foot Ulcer Therapeutic Product One of Innocoll Holdings plc. Table Representative Foot Ulcer Therapeutic Product Two of Innocoll Holdings plc. Table Foot Ulcer Therapeutic Sales, Revenue, Price and Gross Margin of Innocoll Holdings plc. 2013-2017 Table Representative Foot Ulcer Therapeutic Product One of SIGVARIS, Inc. Table Representative Foot Ulcer Therapeutic Product Two of SIGVARIS, Inc. Table Foot Ulcer Therapeutic Sales, Revenue, Price and Gross Margin of SIGVARIS, Inc. 2013-2017